Clinical trials: Vestibular Disorders
Vestibular Function Tests
Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical)
The purpose of this research study is to test whether a Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical) is able to reliably evaluate the vertical semicircular canals in patients with vestibular dysfunctions.
- Trial name
- NCT04087044
- Testing
- Computerized Rotational Head Impulse Test ( crHIT)-Vertical
- Where
- 3 sites in United States
- Volunteers
- 186 people, healthy volunteers welcome
- Sponsor
- Neurolign
Meniere's Disease
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
- Trial name
- AVERTS-2 (NCT02717442)
- Testing
- OTO-104
- Where
- United States
- Volunteers
- 176 people
- Sponsor
- Otonomy, Inc.
Meniere's Disease
OTO-104 for the Treatment of Meniere's Disease
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
- Trial name
- NCT01412177
- Testing
- OTO-104
- Where
- 2 sites in United States
- Volunteers
- 154 people
- Sponsor
- Otonomy, Inc.
MTBI - Mild Traumatic Brain Injury, Vestibular Disease
Effectiveness of VestAid App
This multi-center randomized trial (MCRT) will investigate the effectiveness of the VestAid application to provide equivalent or faster recovery from dizziness compared to standard-of-care delivery of vestibular rehabilitation…
- Conditions
- MTBI - Mild Traumatic Brain Injury, Vestibular Disease, Balance Deficits, Vestibular Disorders
- Trial name
- NCT06683417
- Testing
- Vestibular Rehabilitation Aid, Standard of care vestibular rehabilitation
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- BlueHalo
Vestibular Schwannoma
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
This multi-center, observational, post-intervention LTFU study will monitor for safety and efficacy of AAVAnc80- antiVEGF in individuals with vestibular schwannoma who have previously received an intracochlear administration of…
- Trial name
- NCT07503613
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Akouos, Inc.
Vertigo, Dizziness
Transcranial Vibrating System for Improving Vestibular Physical Therapy
This research study aims to determine whether low-frequency transcranial vibrations can act as a possible treatment for the dizziness and nausea often associated with vestibular physical therapy.
- Conditions
- Vertigo, Dizziness, Nausea, Balance
- Trial name
- NCT03795168
- Testing
- Transcranial vibrating system
- Where
- 2 sites in United States
- Volunteers
- 1 people
- Sponsor
- Otolith Labs
Insomnia, Sleep Disturbance
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Insomnia
Insomnia is known to be one of the most common health concerns in in the general population and has been associated with several health consequences.
- Trial name
- NCT04452981
- Testing
- VeNS
- Where
- 2 sites in Hong Kong, United Kingdom
- Volunteers
- 153 people
- Sponsor
- Neurovalens Ltd.
Anxiety
Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety
Anxiety is known to be one of the most common health concerns in in the general population, and the most common mental health issue, and has been associated with several health consequences.
- Trial name
- NCT05907967
- Testing
- VeNS
- Where
- United Kingdom
- Volunteers
- 83 people
- Sponsor
- Neurovalens Ltd.
Allergy
Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch
Multicentre Phase II trial, comparing two different administration routes of SLITonePLUS Birch in regard to pharmacodynamic efficacy and tolerability.
- Trial name
- NCT01191359
- Testing
- oral immunotherapy
- Where
- Germany
- Volunteers
- 66 people
- Sponsor
- ALK-Abelló A/S
Meniere Disease, Ménière
SPI-1005 for the Treatment of Meniere's Disease
The study is a randomized, double-blind, placebo-controlled, multi-center clinical trial (RCT) with open-label extension study (OLE), of SPI-1005 in adult subjects with definite Meniere's disease with active symptoms within three…
- Trial name
- STOPMD-3 (NCT04677972)
- Testing
- Ebselen
- Where
- 12 sites in United States
- Volunteers
- 220 people
- Sponsor
- Sound Pharmaceuticals, Incorporated
Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss
Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss
The goal of the study was to evaluate the safety, tolerability, and the potential ability of CGF166 delivered through IL-infusion to improve hearing.
- Trial name
- NCT02132130
- Testing
- CGF166
- Where
- 4 sites in United States
- Volunteers
- 22 people
- Sponsor
- Novartis Pharmaceuticals
Type 2 Diabetes
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
This is an open-label, proof of concept study with a single active treatment arm designed to assess whether CVS-based stimulation has a beneficial effect on patients with type 2 diabetes.
- Trial name
- NCT02130401
- Testing
- TNM Device
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Scion NeuroStim
Type 2 Diabetes
Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
Trial Title A randomized, double blind sham controlled clinical trial to evaluate the efficacy of vestibular nerve stimulation (VeNS), together with a lifestyle modification program, compared to a sham control with a lifestyle…
- Trial name
- NCT04595968
- Testing
- Vestal DM Active device, Lifestyle modification
- Where
- 16 sites in United States, Ireland
- Volunteers
- 267 people
- Sponsor
- Neurovalens Ltd.
Migraine Headache
Neurostimulation Device for Treatment of Migraine Headache
This is a single-site, prospective, non-randomized and open label study to investigate the feasibility of home-use CVS for the prevention of episodic migraine headache and specifically to better understand what type of waveform…
- Trial name
- NCT01630044
- Testing
- TNM device
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- Scion NeuroStim
Vertigo, Autonomic Dysfunction
Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo
Study to evaluate the efficacy and safety of Buspirone, sustained-release tablets, 15 mg in patients with autonomic dysfunction syndrome accompanied by vertigo
- Trial name
- NCT05430217
- Testing
- Buspirone
- Where
- 8 sites in Russia
- Volunteers
- 268 people
- Sponsor
- Valenta Pharm JSC
Positional Vertigo, Vertigo
Visual Feedback Goggle for Positional Vertigo Treatment
Benign Paroxysmal Positional Vertigo (BPPV) is one of the most common causes of vertigo and the most common vestibular disorder of the inner ear.
- Trial name
- NCT00729885
- Testing
- Goggle with 20 degree error, Optimized Goggle
- Where
- 3 sites in United States
- Volunteers
- 60 people
- Sponsor
- Vertigone Inc.
Anxiety
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety: A Randomized Clinical Trial
The present study will be conducted at the Department of Physiology in collaboration with the Department of Psychiatry of R.D. Gardi Medical College, Ujjain, Madhya Pradesh.
- Trial name
- NCT05845658
- Testing
- Active VeNS
- Where
- India
- Volunteers
- 60 people
- Sponsor
- Neurovalens Ltd.
Vertigo, BPPV
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
The goal of this virtual clinical trial is to determine the effectiveness of two study devices in providing temporary relief to adults aged 18-70 who suffer from symptoms of chronic vestibular vertigo.
- Conditions
- Vertigo, BPPV, Meniere Disease, Labrynthitis
- Trial name
- NCT05960786
- Testing
- Otoband Experimental
- Where
- United States
- Volunteers
- 109 people
- Sponsor
- Otolith Labs
Vestibular Disease
Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction
The purpose of this study is to determine whether the BrainPort™ balance device is safe and effective in the treatment of balance disorders in patients with Bilateral Vestibular Dysfunction.
- Trial name
- NCT00254228
- Testing
- Electrotactile sensory substitution
- Where
- 5 sites in United States, United Kingdom
- Volunteers
- 60 people
- Sponsor
- Wicab
Dizziness, Vertigo
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
Vestibular disorders are among the most common causes of disability in society and affect over 50% of the population over the age of 65 and a significant percentage of the younger population.
- Conditions
- Dizziness, Vertigo, Vestibular Migraine, Vestibular Neuritis
- Trial name
- NCT05157399
- Testing
- Otoband
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- Otolith Labs